摘要:
The invention proposes a portable, patient-operable analytical device (1) for analysis of a medically significant component of a body fluid for self- monitoring by a patient, in particular a blood glucose measuring device (2), comprising a device housing (3), a measuring facility arranged inside the device housing (3) for carrying out the analysis on a test element (7) that is inserted through a housing opening (8) into the analytical device (1) and the measuring facility, and a processor with software for processing of the measuring values determined by the measuring facility and for processing the measuring values to yield analytical measuring data taking into account calibration values, that is characterized in that it comprises a standardized, wire-based computer interface (4) by means of which the analytical device (1) can be operated by a computer, the analytical measuring data can be transmitted from the analytical device (1) to the computer, and the analytical device (1) is supplied with electrical power by the computer.
摘要:
The device (1) has a measuring device (2) determining measured blood glucose values, and a measured value memory (5) for storing the values. A data interface (6) exchanges data with an external data reading device (7) i.e. personal computer. A data file system (10) has a data reading application for accessing the reading device to read the values. The file system has a testing application to carry out an integrity test for the reading application, while an actual digital signature for the reading application is formed and compared with a digital testing signature provided in the file system. An independent claim is also included for a method for reading measured blood glucose values from a blood glucose measuring device.
摘要:
A blood glucose test instrument kit having modular component parts capable of being assembled into a plurality of different handheld blood glucose test instruments is disclosed. The kit comprises the combination of an interconnection platform adapted to connect to a collection of interoperable modules. The collection of interoperable modules including: a plurality of different measurement engine modules, at least one user interface module, at least one power supply module. A handheld blood glucose test instrument is assembled by the interconnection to the interconnection platform of at least one measurement engine module, at least one user interface module, and at least one power supply module. The inter-module communication among the modules connected thereto to achieve enhanced glucose test instrument reliability by effecting at least one reliability protocol selected from a group of reliability protocols.
摘要:
A blood glucose test instrument kit having modular component parts capable of being assembled into a plurality of different handheld blood glucose test instruments is disclosed. The kit comprises the combination of an interconnection platform adapted to connect to a collection of interoperable modules. The collection of interoperable modules including: a plurality of different measurement engine modules, at least one user interface module, at least one power supply module. A handheld blood glucose test instrument is assembled by the interconnection to the interconnection platform of at least one measurement engine module, at least one user interface module, and at least one power supply module. The inter-module communication among the modules connected thereto to achieve enhanced glucose test instrument reliability by effecting at least one reliability protocol selected from a group of reliability protocols.
摘要:
A device is provided for determining blood glucose characteristics including a display configured for presenting a graphical representation of a plurality of measurements of blood glucose values, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of measurements, based on graphical segments having different graphical styles assigned to different ranges of sensed blood glucose values to indicate a transition from a first range to a second range of sensed blood glucose values. An associated method for operating a device for determining blood glucose characteristics is also provided.
摘要:
Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.
摘要:
The invention proposes a portable, patient-operable analytical device (1) for analysis of a medically significant component of a body fluid for self- monitoring by a patient, in particular a blood glucose measuring device (2), comprising a device housing (3), a measuring facility arranged inside the device housing (3) for carrying out the analysis on a test element (7) that is inserted through a housing opening (8) into the analytical device (1) and the measuring facility, and a processor with software for processing of the measuring values determined by the measuring facility and for processing the measuring values to yield analytical measuring data taking into account calibration values, that is characterized in that it comprises a standardized, wire-based computer interface (4) by means of which the analytical device (1) can be operated by a computer, the analytical measuring data can be transmitted from the analytical device (1) to the computer, and the analytical device (1) is supplied with electrical power by the computer.
摘要:
An electronic device may remotely control a medical device. The electronic device may include a wireless communication circuit configured to wirelessly communicate with the medical device, and a processor that receives from the medical device via the wireless communication circuit screen data generated by the medical device for display on a display device thereof and to control a display device of the electronic device according to the received screen data to display on the electronic device display the screen data generated by the medical device, to emulate at least some of a plurality of user keys of the medical device with selected ones of a plurality of user buttons of the electronic device, and to control the display device of the electronic device to display a map that relates emulated ones of the plurality of user keys to selected ones of the user buttons.
摘要:
According to the inventive method for regulating insulin medication, a patient's blood sugar levels are detected before and after meals. The difference between these two measured values is plotted against a quotient calculated from the carbohydrate units taken up during the meal and the insulin units used to compensate these carbohydrate units. By presenting a number of these points on a chart it is possible to obtain reference points for improving the insulin medication.
摘要:
According to the inventive method for regulating insulin medication, a patient's blood sugar levels are detected before and after meals. The difference between these two measured values is plotted against a quotient calculated from the carbohydrate units taken up during the meal and the insulin units used to compensate these carbohydrate units. By presenting a number of these points on a chart it is possible to obtain reference points for improving the insulin medication.